REN and hypertensive disorder: In this context, it would be interesting to examine its influence in rats with renin–angiotensin–aldosterone system-dependent hypertension, in which a cannabinoid CB1 receptor antagonist has been shown to decrease blood pressure, in contrast to the increase in SHR (see [1]).